Health Care: Drugs

Ligand Pharmaceuticals Inc (LGND: NASDAQ)

$49.4899 1.4099 | 2.93%
07/29/14 - 09:52 AM ET
Company Profile
Price and Volume
Recent Price 48.08
52 Week High 80.42
52 Week Low 39.75
Avg. Daily Vol. (Mil) 0.30
Beta (3 year) 0.99
Share Related Items
Mkt Cap (Mil) 996.48
Shares Out (Mil) 20.73
Float (Mil) 16.03
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.50
Current Ratio 1.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.09
Valuation Ratios
Price Earnings 82.90
Price/Sales 18.70
Price/Book 15.33
Price/Cash Flow 66.20
Per Share Data
Earnings 0.58
Sales 2.57
Book Value 3.14
Cash Flow 0.73
Business Summary
Ligand Pharmaceuticals Inc is a biotechnology company that operates with a business model focused on developing or acquiring assets. It is engaged in development and commercialization of drugs using Captisol technology by CyDex Pharmaceuticals, Inc.
General Information
11119 North Torrey Pines Roa
Suite 200
La Jolla, CA 92037
www.ligand.com
Industry : Drugs
Sector: Health Care
Employees: 20
CEO: Mr. John L. Higgins
Short Interest
Current Month (Mil) 3.21
Previous Month (Mil) 3.42
Short Interest Ratio (Days) 8.80
Management Effectiveness
Return on Equity 18.50
Return on Assets 11.40
Return on Investments 18.50
Profitability
Gross Margin 91.60
EBIT Margin 21.40
Profit Margin 22.60

Portfolios with LGND

Latest LGND Headlines from TheStreet

More Financial News for LGND

Press Releases for LGND

See All Press Releases

Partner Headlines for LGND

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter